Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
AbstractSince its discovery as an oncoprotein in 1979, investigation into p53’s many identities has completed a full circle and today it is inarguably the most extensively studied tumor suppressor (wild-type p53 form or WTp53) and oncogene (mutant p53 form or mtp53) in cancer research. After the p53 protein was declared “Molecule of the Year” by Science in 1993, the p53 field exploded and a plethora of excellent reviews is now available on every aspect of p53 genetics and functional repertoire in a cell. Nevertheless, new functions of p53 continue to emerge. Here, we discuss a novel mechanism that contributes to mtp53’s Gain of Functions GOF (gain-of-function) activities and involves the upregulation of both nucleotide de novo synthesis and nucleoside salvage pathways. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Schmidt, V.; Nagar, R.; Martinez, L.A. Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity. Int. J. Mol. Sci. 2017, 18, 2759.
Schmidt V, Nagar R, Martinez LA. Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity. International Journal of Molecular Sciences. 2017; 18(12):2759.Chicago/Turabian Style
Schmidt, Valentina; Nagar, Rachana; Martinez, Luis A. 2017. "Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity." Int. J. Mol. Sci. 18, no. 12: 2759.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.